mk 0663 has been researched along with estrone in 1 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (estrone) | Trials (estrone) | Recent Studies (post-2010) (estrone) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 10,266 | 432 | 1,372 |
| Protein | Taxonomy | mk 0663 (IC50) | estrone (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.1261 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 6.589 | |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 0.4134 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.301 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.3743 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honjo, H; Iwamoto, K; Uwai, Y | 1 |
1 other study(ies) available for mk 0663 and estrone
| Article | Year |
|---|---|
Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3.
Topics: Animals; Binding, Competitive; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Estrone; Etoricoxib; Humans; Inhibitory Concentration 50; Isoxazoles; Kinetics; Lactones; Methotrexate; Oocytes; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Pyrazoles; Pyridines; RNA, Complementary; Sulfonamides; Sulfones; Xenopus laevis | 2010 |